Assembly Biosciences (ASMB) Capital Expenditures Growth (5y) (2016 - 2026)
Assembly Biosciences (ASMB) Capital Expenditures Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,725.60 Bn | 68,725.31 Bn | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 472.73 Bn | 467.94 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.52 Bn | 116.27 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.74 Bn | 60.99 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - |
| 8 | Argenx Se | 56.42 Bn | 51.24 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.76 Bn | 37.76 Bn | - |
| 10 | Assembly Biosciences | 442.28 Mn | 215.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.47% |
| Sep 30, 2025 | 15.15% |
| Jun 30, 2024 | -15.24% |
| Mar 31, 2024 | 14.97% |
| Dec 31, 2023 | -41.17% |
| Sep 30, 2023 | 82.11% |
| Jun 30, 2023 | -51.78% |
| Dec 31, 2022 | -35.28% |
| Sep 30, 2022 | -19.51% |
| Dec 31, 2021 | -4.71% |
| Sep 30, 2021 | 152.46% |
| Mar 31, 2021 | -178.49% |
| Jun 30, 2020 | 163.09% |
| Mar 31, 2020 | -22.41% |
| Dec 31, 2019 | -35.02% |
| Sep 30, 2019 | 181.91% |
| Mar 31, 2019 | -265.65% |
| Dec 31, 2018 | 176.27% |
| Jun 30, 2018 | 77.88% |
| Dec 31, 2017 | 1,193.34% |